Search

Author/Creator Simo, Magdolna

1. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study. (August 2016)

Authors:
Kovacs, Katalin T; Kalluri, Sudhakar Reddy; Boza-Serrano, Antonio; Deierborg, Tomas; Csepany, Tunde; Simo, Magdolna; Rokusz, Laszlo; Miseta, Attila; Alcaraz, Nicolas; Czirjak, Laszlo; Berki, Timea; Molnar, Tihamer; Hemmer, Bernhard; Illes, Zsolt
Journal:
Multiple sclerosis
Issue:
Volume 22:Number 9(2016)
Page Start:
1192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

Authors:
Sharmin, Sifat; Bovis, Francesca; Malpas, Charles; Horakova, Dana; Havrdova, Eva Kubala; Izquierdo, Guillermo; Eichau, Sara; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Onofrj, Marco; Lugaresi, Alessandra; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro...
Journal:
European journal of neurology
Issue:
Volume 29:Number 8(2022)
Page Start:
2321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. (2nd February 2021)

Authors:
Kalincik, Tomas; Diouf, Ibrahima; Sharmin, Sifat; Malpas, Charles; Spelman, Tim; Horakova, Dana; Havrdova, Eva Kubala; Trojano, Maria; Izquierdo, Guillermo; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grammond, Pierre; Jokubaitis, Vilija; van der Walt, Anneke; Grand'Mai...
Other Names:
author non-byline.; Iuliano Gerardo author non-byline.; Petersen Thor author non-byline.; Verheul Freek author non-byline.; Vella Norbert author non-byline.; Kovacs Krisztina author non-byline.; PetkovskaBoskova Tatjana author non-byline.; Erdelyi Tunde author non-byline.; Dobos Eniko author non...
Journal:
Neurology
Issue:
Volume 96:Number 5(2021)
Page Start:
e783
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis. Issue 3 (17th January 2015)

Authors:
Kalincik, Tomas; Horakova, Dana; Spelman, Tim; Jokubaitis, Vilija; Trojano, Maria; Lugaresi, Alessandra; Izquierdo, Guillermo; Rozsa, Csilla; Grammond, Pierre; Alroughani, Raed; Duquette, Pierre; Girard, Marc; Pucci, Eugenio; Lechner‐Scott, Jeannette; Slee, Mark; Fernandez‐Bolanos, Ricardo; Grand...
Journal:
Annals of neurology
Issue:
Volume 77:Issue 3(2015:Mar.)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Issue 4 (April 2017)

Authors:
Kalincik, Tomas; Brown, J William L; Robertson, Neil; Willis, Mark; Scolding, Neil; Rice, Claire M; Wilkins, Alastair; Pearson, Owen; Ziemssen, Tjalf; Hutchinson, Michael; McGuigan, Christopher; Jokubaitis, Vilija; Spelman, Tim; Horakova, Dana; Havrdova, Eva; Trojano, Maria; Izquierdo, Guillermo;...
Journal:
Lancet neurology
Issue:
Volume 16:Issue 4(2017:Apr.)
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗